In vivo intrinsic efficacy of the 5-HT(1A) receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors

European Neuropsychopharmacology

Volumn 9, Issue 1-2, 1999, Pages 15-19

  Ahlenius, Sven ^a   Henriksson, Ingrid ^a   Magnusson, Olle ^a   Salmi, Peter ^a  

^a Research and Development at Scania Technical Centre   (Sweden)

Author keywords

5 HT(1A) receptors; Dopamine; Male rat; Serotonin; Tryptophan hydroxylase; Tyrosine hydroxylase

Indexed keywords

2 DIPROPYLAMINO 5 FLUORO 8 HYDROXYTETRALIN; 5 HYDROXYTRYPTOPHAN; AMINO ACID DECARBOXYLASE; BRAIN MONOAMINE; BRAIN RECEPTOR; DOPA; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; ENZYME INHIBITOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ROBALZOTAN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG EFFICACY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MONOAMINE METABOLISM; NEOSTRIATUM; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

5-HYDROXYTRYPTOPHAN; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BENZOPYRANS; BRAIN CHEMISTRY; DIHYDROXYPHENYLALANINE; DOPA DECARBOXYLASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HIPPOCAMPUS; HYDRAZINES; MALE; NEOSTRIATUM; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, BIOGENIC AMINE; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS;

EID: 0033004767     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(97)00100-4     Document Type: Article

References (38)

1. Aghajanian, G.K., 1995. Electrophysiology of serotonin receptor subtypes and signal transduction pathways. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp. 451-460..
2. 1A receptor antagonists WAY-100,635 and (S)-UH-301. Eur. Neuropsychopharmacol. 6 (Suppl 4), 151.
3. Ahlenius, S., Hillegaart, V., Wijkström, A., 1989. Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 339, 551-556.
4. Ahlenius, S., Hillegaart, V., Wijkström, A., 1990. Increased dopamine turnover in the ventral striatum by 8-OH-DPAT administration in the rat. J. Pharm. Pharmacol. 42, 285-288.
5. Andén, N.-E., 1980. Regulation of monoamine synthesis and utilization by receptors. In: Szekeres, L. (Ed.), Handbook of Experimental Pharmacology. Springer-Verlag, Berlin-Heidelberg, pp. 429-462.
6. 1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 347, 353-362.
7. Arvidsson, L.E., Hacksell, U., Nilsson, J.L.G., et al., 1981. 8-Hydroxy-2-(di-N-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J. Med. Chem. 24, 921-923.
8. Benloucif, S., Keegan, M.J., Galloway, M.P., 1993. Serotonin- facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther. 265, 373-377.
9. 1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino) tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino) tetralin-induced effects. J. Pharmacol. Exp. Ther. 258, 58-65.
10. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane anesthetized rat. Neuropharmacology 34, 269-279.
11. Carlsson, A., Davis, J.N., Kehr, W., Lindqvist, M., Atack, C.V., 1972. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 153-168.
12. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res. 543, 354-357.
13. Ennis, C., Kemp, J.D., Cox, B., 1981. Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J. Neurochem. 36, 1515-1520.
14. 1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol. Sci. 14, 441-448.
15. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 281, 81-88.
16. Gerber, R., Barbaz, B.J., Liebman, J.M., 1988. Rotational behavior induced by 8-hydroxy-DPAT, a putative 5-HT-1A agonist, in 6-hydroxydopamine-lesioned rats. Psychopharmacology 94, 178-182.
17. 2A/c receptors in the expression of patterns of spontaneous motor activity in the rat. Eur. J. Pharmacol. 295, 155-161.
18. Hillegaart, V., Hjorth, S., Ahlenius, S., 1990. Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. J. Neural Transm. [GenSect] 81, 131-145.
19. 1A receptor antagonist. J. Med. Chem. 33, 1541-1544.
20. Hjorth, S., Carlsson, A., 1985. (-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis. Neuropharmacology 24, 1143-1146.
21. Hjorth, S., Carlsson, A., Lindberg, P., et al., 1982. 8-Hydroxy-2-(di-N-propylamino)tetralin, 8-OH-DPAT, a potent an selective simplified ergot congener with central 5-HT-receptor stimulating activity. J. Neural Transm. 55, 169-188.
22. Hutson, P.H., Sarna, G.S., O'Connell, M.T., Curzon, G., 1989. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OH-DPAT into the nucleus raphe dorsalis. Neurosci. Lett. 100, 276-280.
23. 1A receptor antagonist, NAD-299. J. Pharmacol. Exp. Ther. 283, 216-225.
24. 1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum. J. Pharmacol. Exp. Ther. 266, 133-141.
25. 1A receptor antagonist, to rat brain. J. Neurochem. 64, 2716-2726.
26. 1A receptors in the rat central nervous system. J. Comp. Neurol. 365, 289-305.
27. Li, X.-M., Perry, K.W., Fuller, R.W., 1996. On the in-vivo modulation of neostriatal dopamine release by fluoxetine and 5-hydroxy-L-tryptophan in conscious rats. J. Pharm. Pharmacol. 48, 825-828.
28. Magnusson, O., Nilsson, L.B., Westerlund, D., 1980. Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography-electrochemical detection system. J. Chromatogr. 221, 237-247.
29. Palacios, J.M., Waeber, C., Hoyer, D., Mengod, G., 1990. Distribution of serotonin receptors. Ann. NY Acad. Sci. 600, 36-52.
30. Prisco, S., Pagannone, S., Esposito, E., 1994. Serotonin-dopamine interaction in the rat ventral tegemental area: an electrophysiological study in vivo. J. Pharmacol. Exp. Ther. 271, 83-90.
31. 2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons - a quantitative autoradiographic study. Brain Res. 606, 273-285.
32. 1 receptor. Eur. J. Pharmacol. 157, 173-181.
33. Smith, C.F.C., Cutts, S., 1990. Dopamine agonist activity of 8-OH-DPAT. Arch. Int. Pharmacocyn. Ther. 306, 106-113.
34. Sharp, T., Bramwell, S.R., Hjorth, S., Grahame-Smith, D.G., 1989. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br. J. Pharmacol. 98, 989-997.
35. 1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur. J. Pharmacol. 106, 271-282.
36. Winer, B.J., 1971. Statistical Principles in Experimental Design. McGraw-Hill, New York.
37. 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351, 357-373.
38. Yadid, G., Pacak, K., Kopin, I.J., Goldstein, D.S., 1994. Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmacol. Exp. Ther. 270, 1158-1165.